Open AccessComparative effectiveness and safety of 32 pharmacological interventions recommended by guidelines for coronavirus disease 2019: a systematic review and network meta-analysis combining 66 trials
Author(s) -
Shanshan Wu,
Qingxin Zhou,
Xueyang Zeng,
Jing-Xue Zhang,
Zhirong Yang,
Qingqing Yang,
Zi-Lu Zhang,
Yahong Chen,
Feng Sun,
Siyan Zhan
Publication year - 2021
Publication title -
chinese medical journal/chinese medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 63
eISSN - 2542-5641
pISSN - 0366-6999
DOI - 10.1097/cm9.0000000000001672
Subject(s) - meta analysis , medicine , psychological intervention , systematic review , covid-19 , medline , coronavirus , intensive care medicine , disease , virology , infectious disease (medical specialty) , psychiatry , biology , outbreak , biochemistry
The global pandemic coronavirus disease 2019 (COVID-19) has become a major public health problem and presents an unprecedented challenge. However, no specific drugs were currently proven. This study aimed to evaluate the comparative efficacy and safety of pharmacological interventions in patients with COVID-19.